Novartis Singapore’s Post

It has been a year since I became CCO for Astellas and given how regularly I am asked what that involves, it feels only right that I try and explain more about my role. With responsibility for the P&L from our Commercial operations, my job may appear to be all about the numbers when, in actual fact, it is more about the people. First and foremost, our patients. It is my job to make sure we bring our innovative medicines to customers, so they can optimally treat and bring value to patients’ lives. But to deliver on that promise takes vision and cohesion, which is why the lion’s share of my internal focus this year has been on building a high-performing, cross-functional team. The success of the Growth Strategy – which identified how we could potentially impact the lives of over nine million more patients – has exceeded all expectations and been a major highlight of the past year. But, of course, Commercial is only one part of a much bigger whole.    Bringing breakthrough discoveries to patients relies on collaboration and partnerships with stakeholders right across the healthcare ecosystem. This is why I value and devote so much time to engaging with healthcare experts, patient groups, government agencies, media and, through my board membership of EFPIA, industry peers: to ensure we support patient access and bring the greatest possible benefit to the lives of our patients globally.    Regular touchpoints with our valued investor community to keep them appraised of the future trajectory and evolution of our business is another vital and fulfilling aspect of my work.    Every conversation reveals something new and inspires me to keep pushing, driving and aspiring for more. Being Astellas CCO is a privilege and I intend to continue extracting every last drop of potential out of every single day!  

Africa Cluster

Michel Demaré, Chair of the Board at AstraZeneca Plc, and Chairman of the Foundation and Supervisory Boards at IMD, presented at the launch of our Role of the Chair session IMD. With his experience in 9 industries across 4 continents, Mr. Demaré’s view on the role of the chair is crystallised: “Attitude is the most important trait for this role - there's no room for egos. The CEO is the window of the company, and it’s my role to ensure he/she is successful. I consider myself a mentor, offering guidance, bouncing ideas, and providing support.” He emphasises that Emotional Intelligence (EQ) is more important than IQ for being a chair. “It is about empathy, listening to people, focusing on detecting and developing talents, and managing relationships with all stakeholders.” Regarding CEO succession, Mr. Demaré mentioned that it involves regular evaluations and transparent discussions, benchmarking candidates on attitude, personality, and management style to ensure readiness for future challenges. It is essential to fully involve the CEO in the process. As a chair, he meets the candidates on a regular basis and socialises to get to know them better. An important part of his job is to engage, not only with the executives, but with as many employees as possible to explain to them the role of the board and understand diverse perspectives. As the chair of one of the largest pharmaceutical companies in the world, the company is dedicated to going beyond business – e.g. initiatives for improving the resilience of health systems and fostering public-private partnerships. Nonetheless, while long-term strategic thinking is crucial in healthcare, the fast pace of change in science and business forces boards to also focus on shorter-term milestones. What is important is to get the right balance between long-term and short-term strategy.” 💡 These are key takeaways from the session 💡: -         Governance and Strategy: To understand the role of the chair, it is a prerequisite to understand the role of the board. It’s all about governance, strategy and people. Ensuring an understanding of governance is essential. Promoting a positive culture and ensuring a cooperative, respectful environment is also crucial. -         Managing Chair-CEO Relationships: The relationship between the CEO and the Chair is key. This is not a competition, but a constructive, yet challenging relationship. The chair’s ultimate satisfaction is to see the CEO shine. Regular engagement with the CEO, and building a relationship based on mutual respect and trust are essential for organisational success. In the complex and fast-paced business environment today, it is imperative to explore the right role of the chair for effective governance of organisations. Learn more about the program here: https://bit.ly/3wNIVTB, and about the Board & Governance programs here: https://bit.ly/3R95dG3 #IMDImpact #IMDBoardCenter #HighPerformanceBoards #CorporateGovernance #BoardofDirectors #BoardChair

In this week's episode on The Scrubbed In Show, Samuel Hollis (Novartis UK) shares his journey in the pharmaceutical industry, a career spanning close to 2 decades working in the UK, Switzerland and US in roles from sales rep, medical affairs to global marketing and business unit head to now gearing up to start as a country president in Central Europe, not to mention his 🦞 theory! We discussed: 🏥 The role of medical affairs and why people should join the industry 🌟 Why 21st century leadership is about authenticity, vulnerability and entrepreneurship 💊 The process of a medicine coming to market 🇬🇧🇺🇸 Learnings from working in the UK vs US 🔬 The importance of innovation and staying competitive 🛠️ Building real solutions to real problems 🔄 Transitioning from AstraZeneca to Novartis UK 🌱 Growth and leadership mindset 🦞 'Be More Lobster' 🤝 Why collaboration and partnerships between healthcare systems and industry are built on trust 💼 The reputation of pharma and myth busting 🔨 How to build trust and 'Purpose-led collaborations' 📉 Learning from failures, commercial R&D and building the right working cultures 🌍 New role as country president at Novartis 🎓 Tips for building a career in the pharma industry Link in the comments!

Let's look back to the remarkable achievements of the Prix Galien 2023 USA winners. 🏆 Let's take a trip down memory lane and remember the extraordinary innovations that continue to shape the landscape of healthcare. To Bristol Myers Squibb, Eli Lilly and Company, Boehringer Ingelheim, CSL / uniQure, Guardant Health, Medable, Inc, Villgro Africa, GrayMatters Health, and Volta Medical: Your contributions have left an indelible mark on the world of healthcare. Your vision, dedication, and unwavering commitment to excellence have inspired us all. As we reflect on this special moment, we're reminded of the boundless potential of human ingenuity and the power of innovation to transform lives. Here's to the enduring legacy of the Prix Galien winners and the hope they continue to bring to patients worldwide. Join us in honoring these visionary leaders and innovators as we look back on a year filled with groundbreaking achievements. #throwbackthursday #PrixGalien #healthcareinnovation #medicalresearch #pharmaceuticalindustry #biotechnology

👤 Get to know Sandra Orta, General Manager of Bristol Myers Squibb Spain & Portugal, more closely through this interview in La Vanguardia, which reviews part of her career, her particular #leadership philosophy and the Industry's opportunity to generate great impact and transform the world 📌 From her past in management positions in important multinationals and in different countries, to her present where she combines being a single mother with the management of #BMSIberia, Sandra Orta is clear: "I would like my legacy here to have left people happier." ➕ Because in addition to our innovative #Science, strong investment in R&D and the 136 clinical trials we currently have underway to positively impact #patients and respond to their unmet needs, our General Manager puts the focus on #diversity and the transformation of BMS' corporate #culture. 🗨️ "Companies are too hierarchical, but the whip doesn't work," Orta stresses. Instead, as a manager, she tries to "be one of the team, give them a voice and think about how I can help them. This strategy has worked for me everywhere: people feel more supported, work harder and with more enthusiasm. Access the full article at ➡️ https://lnkd.in/dRH5He9N #BMSIberia #BMSPortugal #BMSCommunity #BMSTransformingLives #WorkingTogetherforPatients #BMSTransformingPatientsLive

The recent three-day face-to-face in Madrid with the International Markets leadership team was nothing short of inspiring. We took a step back to reflect on our journey so far, including 3+ years of continuous growth, and set our sights on what’s to come. The energy in the room was contagious as we mapped out our key milestones, sparking dynamic conversations. What really stood out was the passion and drive from everyone in the room. It was more than just aligning on our business and our part in Teva Pharmaceuticals' #PivotToGrowth strategy - it was about reconnecting with one another, reigniting our collective purpose, and getting excited about the path ahead. This year has brought its challenges, but this gathering reminded us of the power of partnership and what we can achieve when we work together - across regions, across markets, and toward a shared vision of growth. We’re heading into 2025 with a renewed sense of purpose, and I can’t wait to see how we’ll continue to push forward, together. Asaf Regev Jim Margaritis Rodrigo Fernandez Igor Shtainberg Efi Benmeir Tal Zorman Yoav Motola Rinat Shiran-Rasky Erick Roche Theodor Wee Vadym Olimpiev Alexander Konstantinidis Fabien Paquette #Leadership #SustainableGrowth #Profitability #Teamwork #Innovation #TevaPharmaceuticals

Who are the "Top 5 CRO's to watch in 2024"? 👀 Here's my pick and why..... 1. IQVIA - IQVIA operates in over 100 countries and has approximately 87,000 employees making the organisation one of the biggest in the space. 💊 2. Charles River Laboratories - Charles River was jointly named “Best Contract Research Organisation (with NJ Bio, Inc.) at the 10th Annual World ADC Awards 2023. 👩🔬 3. Syneos Health - Syneos Health® received the 2023 ViE (Vaccine Industry Excellence) Award and PM360 2023 Innovator in Clinical Trials. 👨🔬 4. Caidya - In 2023, Caidya won the CRO Leadership Award for Overall Capabilities at the CRO Leadership Awards. 🏅 5. TFS HealthScience - For the fourth consecutive year, TFS received a Silver Rating from EcoVadis in 2023, placing it in the top 8% for sustainability excellence, a distinction that reinforces TFS’s commitment to corporate sustainability. 🌳 Let me know your thoughts and who you would put in your Top 5 in the comments below ⬇ #top5 #cro #award #thoughts

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork

Celebrating Leadership and Innovation at Teva As we embrace Teva’s new business strategy, the commercial SLT team of Teva in Bulgaria put a dedicated focus on the power of our new leadership principles in steering our company towards success. 🤝We were hosted by our colleagues from Teva Dupnitsa production plant where Innovation meets Tradition. This year, the plant celebrates its 70th anniversary, we honor a legacy of excellence that has significantly contributed to the Bulgarian pharmaceutical industry and Teva’s global manufacturing prowess. The plant’s history is a testament to the professionalism and dedication that runs deep within our company’s DNA. 🚀 Teva“Pivot to Growth” strategy is built on four pillars designed to propel Teva into a future of growth and innovation. By accelerating our innovative medicines portfolio, expanding our pipeline, sustaining our generics powerhouse, and focusing on high-impact areas, we’re setting the stage for a healthier tomorrow. 🤝 We, as leaders, believe that Unity and Collaboration success at Teva is a collective effort. It’s about putting the enterprise first and fostering collaboration across all facets of our business. Our teams are inspired and motivated, working together to surpass our business targets and make a meaningful impact. 💡 Our new leadership principles are more than guidelines; they’re a call to action. We lead with integrity and accountability, ensuring every decision aligns with our mission to improve patient health worldwide. 🤝Our commitment to humility, clarity, and ambition is not just a mantra but the foundation of our transformative journey. Let’s continue to build bridges, inspire each other and uphold the values that make Teva a leader in healthcare. Here’s to many more years of making a difference! #tevabulgaria #Leadership #Innovation #Healthcare #PivotToGrowth #Teamwork